Elevance Health Rebounds on Strong Q1, but CMS Sanction Overhang Lingers

What happened

Elevance Health surged ~34% from its March lows after reporting Q1 2026 revenue of $49.5B (up 1.5%) and adjusted EPS of $12.58 (up 5.1%), beating expectations and prompting management to raise full-year adjusted EPS guidance to at least $26.75. The company also guided for a return to 12% adjusted EPS growth in 2027, signaling confidence in underlying earnings power despite the challenging medical cost environment. However, the DeepValue report maintains a WAIT rating (conviction 3.5) given the unresolved CMS Medicare Advantage-Prescription Drug (MA-PD) sanctions that could suspend enrollment and communications if not resolved by mid-2026. The benefit expense ratio (BER) improvement to 86.8% in Q1 is encouraging, but the FY2026 guidance of 90.2% ±50 bps is still at elevated levels that demand close monitoring. The stock's recent rally reflects operational recovery, but the thesis hinges on two binary gates: CMS sanction resolution by June 30 and BER staying within guided range.

Implication

The Q1 beat and raised guidance improve the fundamental backdrop, but the investment thesis remains gated by the pending CMS decision. Investors should hold off until at least June 30 to see if sanctions are lifted, as that would remove the primary overhang. If sanctions are resolved and BER remains in check, the stock could re-rate toward the $350 base case scenario, but current entry near $317 is above the attractive threshold of $295. A disciplined approach favors waiting for a clearer catalyst or a pullback.

Thesis delta

The positive Q1 results and raised guidance strengthen the recovery narrative but do not alter the central thesis that CMS sanction risk is the near-term driver. The improvement in fundamentals reduces downside tail risk but the stock is no longer at a deep discount, having rallied above the $295 attractive entry. The wait rating remains appropriate as the path to a full re-rate requires two observable events: CMS clearance and sustained BER discipline.